|Application:||Gene expression microarray analysis, ChIP-on-chip analysis|
|Number of samples:||244|
|Release date:||May 23 2012|
|Last update date:||May 15 2017|
|Diseases:||Hamartoma Syndrome, Multiple, Neoplasms, Prostatic Neoplasms, Intracranial Hypertension|
|Dataset link||The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer|
Gene expression profiling and array CGH (aCGH) was performed on matched benign prostate tissues (n=28), localized prostate cancer (n=59), and metastatic castrate resistant prostate cancer (CRPC, n=35). For gene expression profiling, frozen prostate tissue samples (channel 2), were hybridized against a commercial pool of benign prostate tissue (Clontech, channel 1). For aCGH, frozen prostate tissue samples (channel 2) were hybridized against a commerical sample of Human Male Genomic DNA (Promega, channel 1).
Citations per year